Experience and Lessons Learned in Biosimilar Uptake - Nexus 2018



ACPE UAN #:  0233-0000-18-064-H04-P

Release DateOctober 24, 2018

Expiration Date:  October 24, 2021

Activity Type:    Knowledge-based

Contact Hours:  1.5

Activity Fee:  Member:  Free        Non-Member: $30

Target Audience: Pharmacists who practice in managed care settings.

Activity overview

Although biosimilars have been on the market for some time, payers continue to face many challenges in implementation. However, some organizations have been able to overcome these barriers.  For instance, Inflectra (infliximab-dyyb), a biosimilar to Remicade (infliximab), was approved in 2016 but has limited uptake in the United States. Kaiser Permanente was one of the few health systems to implement the use of Inflectra starting in 2017. Today, Kaiser Permanente Northwest has 90% Inflectra utilization compared to 10% Remicade utilization. This session will discuss the biosimilar experience and barriers to uptake across managed care pharmacy. 

The session will also take a deeper dive into a case study of Kaiser Permanente’s experience with Inflectra (infliximab-dyyb) in rheumatology, dermatology, and gastroenterology, and share lessons learned with other payers facing the same challenges with biosimilar conversions.

Learning Objectives:  

At the completion of this activity, participants should be able to:

  1.    Discuss challenges and opportunities in biosimilar implementation across the managed care pharmacy landscape.
  2.    Outline key steps in implementing a successful biosimilar conversion.
  3.    Identify potential challenges to converting patients from the reference product to a biosimilar for an infused medication.

Schedule of Educational Activity

This activity consists of an audio recording, pre-test assessment questions (not required to pass or continue), post-test questions (required to pass with a score of 70% or higher) and a specific activity evaluation. 

 

The Academy of Managed Care Pharmacy (AMCP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

As an accredited provider, AMCP strictly adheres to the ACPE Standards for Commercial Support and other relevant guidelines and standards to ensure the independence of continuing pharmacy education (CPE) activities.  It is AMCP’s intent that all CPE activities be independent, objective, balanced, evidence-based and free of any commercial bias.

CPE Requirements:   

Participants should claim continuing pharmacy education (CPE) credit for this home study activity only if they have not claimed credit for the live activity presented at AMCP Nexus 2018.  CPE credit will be processed through the AMCP Learn portal and reported directly to CPE Monitor.  Please allow 72 hours for processing and posting in your NABP account.

To receive credit for an online activity you must:

  • Review the full content of the activity.
  • Successfully complete the post-test (required to pass with a score of 70% or higher, it may be taken a maximum of three times).
  • Complete a specific activity evaluation.

System Technical Requirements/Viewing Requirements: System Requirements Courses and learning activities are delivered via your Web browser and Acrobat PDF. For all activities, you should have a basic comfort level using a computer and navigating web sites.  View the minimutechnical and system requirements for continuing education online learning activities.

Moderator:

Grant Knowles, PharmD, CSP | Vice President, Operations & Business Development | Ardon Health | Portland, Oregon.

Credit Information

Activity Number Credit Amount Accreditation Period
ACPE UAN #0233-0000-18-064-H04-P 1.5 Contact Hours October 24, 2018 - October 24, 2021